- Quarter end
- 31 Dec 2023
- the date the book describes
- Filed
- 14 Nov 2024
- latest of these filings; the earliest 8 Feb 2024
- Managers listing it
- 20
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2023 and Q4 2023; 15 listed it in both
- Shares listed
- 11,171,118
- combined, among listed positions
- Reported value
- $2.8bn
- combined, at the quarter end
Among the 93 comparable managers: 12 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing SBAC in Q4 2023
20 of 20 holders
Largest increases and reductions, by shares
Increases
- Citadel Advisors LLCexisting position · 2,652,866 shares now+1,340,772
- Millennium Management LLCexisting position · 1,080,499 shares now+665,938
- Akre Capital Management LLCnew position · 180,629 shares now+180,629
- MFS Investment Managementexisting position · 1,958,156 shares now+166,554
- Hudson Bay Capital Management LPnew position · 85,000 shares now+85,000
Reductions
- T. Rowe Price Associates Incexisting position · 952,980 shares now-223,670
- Capital Research Global Investorsexisting position · 456,515 shares now-187,728
- Invesco Ltdexisting position · 2,100,858 shares now-43,019
- Schonfeld Strategic Advisors LLCexisting position · 208,632 shares now-30,824
- AllianceBernstein LPexisting position · 531,783 shares now-11,217
New positions and exits
New (4)
Exited (1)
- Two Sigma Investments LPwas $30m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2016 | 1 | $50m | n.a. | n.a. |
| Q1 2017 | 18 | $2.3bn | n.a. | n.a. |
| Q2 2017 | 16 | $2.0bn | n.a. | n.a. |
| Q3 2017 | 17 | $1.7bn | n.a. | n.a. |
| Q4 2017 | 17 | $2.0bn | n.a. | n.a. |
| Q1 2018 | 21 | $2.5bn | n.a. | n.a. |
| Q2 2018 | 16 | $2.4bn | n.a. | n.a. |
| Q3 2018 | 20 | $2.1bn | n.a. | n.a. |
| Q4 2018 | 18 | $2.0bn | n.a. | n.a. |
| Q1 2019 | 15 | $2.3bn | n.a. | n.a. |
| Q2 2019 | 19 | $3.0bn | n.a. | n.a. |
| Q3 2019 | 25 | $3.6bn | n.a. | n.a. |
| Q4 2019 | 23 | $3.5bn | n.a. | n.a. |
| Q1 2020 | 28 | $4.3bn | n.a. | n.a. |
| Q2 2020 | 30 | $4.9bn | n.a. | n.a. |
| Q3 2020 | 23 | $5.0bn | n.a. | n.a. |
| Q4 2020 | 23 | $5.0bn | n.a. | n.a. |
| Q1 2021 | 18 | $4.4bn | n.a. | n.a. |
| Q2 2021 | 26 | $4.8bn | n.a. | n.a. |
| Q3 2021 | 22 | $4.8bn | n.a. | n.a. |
| Q4 2021 | 27 | $5.5bn | n.a. | n.a. |
| Q1 2022 | 19 | $4.6bn | n.a. | n.a. |
| Q2 2022 | 18 | $4.8bn | n.a. | n.a. |
| Q3 2022 | 19 | $4.3bn | n.a. | n.a. |
| Q4 2022 | 22 | $4.3bn | n.a. | n.a. |
| Q1 2023 | 24 | $2.9bn | n.a. | n.a. |
| Q2 2023 | 22 | $2.4bn | n.a. | n.a. |
| Q3 2023 | 21 | $2.0bn | n.a. | n.a. |
| Q4 2023 | 20 | $2.8bn | 12 | 9 |
| Q1 2024 | 23 | $2.4bn | 16 | 8 |
| Q2 2024 | 21 | $2.0bn | 15 | 6 |
| Q3 2024 | 21 | $2.6bn | 12 | 11 |
| Q4 2024 | 19 | $2.8bn | 9 | 13 |
| Q1 2025 | 19 | $3.3bn | 12 | 8 |
| Q2 2025 | 14 | $3.0bn | 8 | 8 |
| Q3 2025 | 12 | $2.5bn | 11 | 3 |
| Q4 2025 | 10 | $3.2bn | 17 | 14 |
| Q1 2026 | 12 | $3.0bn | 19 | 15 |
| Q2 2026 | 10 | $2.9bn | 16 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
SBAC and WELL →SBAC and EQIX →SBAC and PLD →Choose a stock to compare with SBAC →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own SBAC, latest filings →Back to the 13F Explorer →